New CPT code now effective for second level of lumbar total disc replacement procedures


Centinel Spine has revealed that, from 1 January 2023, providers are able to utilise a new Current Procedural Terminology (CPT) code when performing two-level lumbar total disc arthroplasty via an anterior approach.

To increase the availability of two-level lumbar total disc replacement (TDR) to individuals experiencing degeneration of the intervertebral discs, the American Medical Association (AMA) accepted the addition of a new Category I CPT code for a second level of lumbar TDR in late 2021. According to Centinel Spine, the prodisc L is the only total disc replacement system in the US approved for two-level use in the lumbar spine.

New CPT codes are created after review by the AMA CPT editorial panel and minimally meet several criteria, including:

  • The device is FDA approved
  • The procedure is performed by many physicians across the USA
  • The procedure is performed with frequency consistent with the intended clinical use (i.e., a service for a common condition should have high volume)
  • The procedure is consistent with current medical practice
  • The clinical efficacy of the procedure is documented in literature that meets the requirements set forth in the CPT code-change application

Vivek Mohan, an orthopaedic spine surgeon from the Orthopaedic Spine Institute (Schaumburg, USA), said: “This new CPT code will allow more patients access to two-level lumbar total disc replacement. There is a significant number of patients with symptomatic two-level degenerative disc disease in the lumbar spine, and this will impact their ability to benefit from the advantages of lumbar disc replacements.”

Centinel Spine CEO, Steve Murray, added: “Through the efforts of physician partners and medical societies, this new CPT code expands access to life changing technologies for patients by opening new reimbursement pathways. The prodisc L device is the only disc that has FDA approval for two-level indications and has been a benefit for patients with lumbar disc disease of this severity. Having two-level approval has helped Centinel pursue its mission to provide clinically-proven products that allow individuals to continue to function at a high level.”


Please enter your comment!
Please enter your name here